About
G. Paul Amminger, MD, PhD, is affiliated with Orygen and the Centre for Youth Mental Health at the University of Melbourne, Australia. His publications from 2007 to 2022 focus on schizophrenia and schizoaffective disorders, child and adolescent psychiatry, neurology, and anxiety. His research includes clinical trials and reviews on interventions for young people at ultra-high risk of psychosis, treatment-resistant anxiety disorders, and dosing strategies for antipsychotic medications. He has frequently collaborated with colleagues such as Patrick D. McGorry and Alison R. Yung.
